Cyclacel Pharmaceuticals Inc (NASDAQ:CYCCP)
| 7.66 Data as of May 21 |  0.00 / 0.00%Today’s Change | 2.06 Today|||52-Week Range 10.45 | +53.10% Year-to-Date |
Latest CYCCP News | Press Releases
| Top Insider Trades: RH, AMBI, LULU, CYCC 9:20am / TheStreet.com |
Today’s Trading
| Previous close | 7.66 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 232 |
| Market cap | $6.1M |
| Dividend yield | 7.84% |
Data as of 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TELKTelik Inc | 0.00 | 0.00% |
| TPIVTapImmune Inc | +0.01 | +23.20% |
| ABIOARCA Biopharma Inc | 0.00 | 0.00% |
| ANDFAndain Inc | -0.01 | -16.67% |
Data as of 3:59pm ET, 05/23/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
Chart unavailable